MedPath

High Protein Intake in Critically Ill Ventilated Patients

Completed
Conditions
Intensive Care Unit Syndrome
Registration Number
NCT04977440
Lead Sponsor
Cairo University
Brief Summary

This prospective interventional randomized control study was conducted on forty patients with respiratory failure; all patients were intubated and mechanically ventilated for at least three days. Twenty patients received high protein intake using whey protein, with daily follow-up of the blood sugar level, serum electrolytes, and chemistry. ICU outcome regarding food intolerance, 30-day mortality, length of MV and ICU-stay was recorded

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age >18 years
  • Mechanically ventilated patients (for three days or more )
Exclusion Criteria
  • Age < 18 years old
  • Contraindication for enteral nutrition (gut ischemia, obstruction, or perforation)
  • Expected intolerance for enteral nutrition (paralytic ileus)
  • Inability to start enteral nutrition within 24-hours(i.e. surgery or other interventions)
  • Short bowel syndrome
  • Hemodynamic instability ( i.e shock state, need for vasopressors )
  • Child C liver cirrhosis or acute liver failure
  • Dialysis dependency

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of high protein intake on serum electrolytesup to 7 days

measurements of Na, K, Mg, phosphorous and calcium levels regularly after high protein intake

Effect of high protein intake on glycemic controlup to 7 days

measurements of blood glucose levels regularly after high protein intake

Secondary Outcome Measures
NameTimeMethod
Effect of high protein intake on ICU outcomeup to 7 days

ICU outcome includes ICU survival , mechanical ventilation , food intolerance

Trial Locations

Locations (1)

Cairo University Hospitals

🇪🇬

Cairo, Egypt

Cairo University Hospitals
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.